Patent ID: 9018217
Filing Date: 2015-04-28
Classification: A61K,A61P,C07D

Abstract:
1. A compound having the structure I wherein HET is selected from the group consisting of [1,2,4]triazolo[1,5-a]pyridine, imidazo[1,2-a]pyridine, pyrazolo[1,5-a]pyridine, 5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyridine, 5,7-dimethyl-imidazo[1,2-a]pyridine, 5-chloro-imidazo[1,2-a]pyridine, 5-methyl-imidazo[1,2-a]pyridine, 5-trifluoromethyl-imidazo[1,2-a]pyridine, 6-Bromo-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyridine, 6-bromo-7-methyl-[1,2,4]triazolo[1,5-a]pyridine, 6-chloro-8-methyl-[1,2,4]triazolo[1,5-a]pyridine, 6-chloro-imidazo[1,2-a]pyridine, 7-methyl-[1,2,4]triazolo[1,5-a]pyridine and 8-methyl-imidazo[1,2-a]pyridine, -L- is a linker selected from —CH R R and tautomers and pharmaceutically acceptable acid addition salts thereof, and polymorphic forms thereof.